Publication:
Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect.

dc.contributor.authorLópez-Campos, José Luis
dc.contributor.authorFernández-Villar, Alberto
dc.contributor.authorRuano-Ravina, Alberto
dc.date.accessioned2023-02-09T10:39:41Z
dc.date.available2023-02-09T10:39:41Z
dc.date.issued2021
dc.identifier.doi10.1164/rccm.202012-4386LE
dc.identifier.essn1535-4970
dc.identifier.pmcPMC8017588
dc.identifier.pmid33444512
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017588/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1164/rccm.202012-4386le
dc.identifier.urihttp://hdl.handle.net/10668/16973
dc.issue.number7
dc.journal.titleAmerican journal of respiratory and critical care medicine
dc.journal.titleabbreviationAm J Respir Crit Care Med
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number925-926
dc.pubmedtypeComparative Study
dc.pubmedtypeLetter
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshBronchodilator Agents
dc.subject.meshBudesonide
dc.subject.meshDrug Combinations
dc.subject.meshFemale
dc.subject.meshFormoterol Fumarate
dc.subject.meshGlycopyrrolate
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPulmonary Disease, Chronic Obstructive
dc.subject.meshTreatment Outcome
dc.titleTriple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number203
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8017588.pdf
Size:
572.53 KB
Format:
Adobe Portable Document Format